Tear proteomics reveals expressed proteins and potential pathways associated with diabetic keratopathy

泪液蛋白质组学揭示了与糖尿病性角膜病变相关的表达蛋白和潜在通路。

阅读:1

Abstract

BACKGROUND: Patients with diabetes are at risk of developing diabetic keratopathy (DK). The pathophysiological mechanisms of DK and associated biomarkers remain unclear. However, tear analysis provides crucial insights into DK. Thus, we conducted a quantitative proteomic analysis of tears from DK patients to identify differentially expressed proteins and potential pathways associated with DK. METHODS: This prospective case-controlled study included patients admitted to Zhujiang Hospital between October 2022 and February 2023. We examined 22 eyes with DK and 11 control eyes without DK. General characteristics and dry eye-related features were recorded, including those observed using ocular surface analysis, conjunctival impression cytology, and tear ferning tests. Tear fluid was collected using Schirmer strips after ensuring group similarity in confounders. Proteins were analysed through four-dimensional label-free mass spectrometry. Differential proteins were subjected to analyses of Gene Ontology (GO) and Kyoto Encyclopedia of Genes and Genomes (KEGG) analyses. A protein-protein interaction network map was constructed. RESULTS: Of the 2733 proteins identified, 313 (156 upregulated and 157 downregulated) differentially expressed proteins were screened. GO analysis revealed that these differentially expressed proteins mainly participated in mRNA decay, nuclear transcription, and receptor-mediated endocytosis. KEGG analysis showed that these differentially expressed proteins could be involved in pathways, such as arginine biosynthesis, extracellular matrix-receptor interactions. CONCLUSIONS: Arginine biosynthesis and extracellular matrix-receptor interactions may be involved in DK pathogenesis, and VDAC3 may be a potential biomarker for DK. These findings would enhance the understanding of DK among ophthalmologists as well as help in developing novel strategies for its treatment.

特别声明

1、本页面内容包含部分的内容是基于公开信息的合理引用;引用内容仅为补充信息,不代表本站立场。

2、若认为本页面引用内容涉及侵权,请及时与本站联系,我们将第一时间处理。

3、其他媒体/个人如需使用本页面原创内容,需注明“来源:[生知库]”并获得授权;使用引用内容的,需自行联系原作者获得许可。

4、投稿及合作请联系:info@biocloudy.com。